Dfarma
- 0847.890.559
- BE0847890559
- Kerkstraat 16, 8400 Oostende
- 3 August 2012
Profile
Official information from the CBE (FPS Economy).
Dfarma is a Belgian company (Société en commandite) whose registered office is established at 8400 Oostende. Its main activity falls under “Activités de société holding” (NACE 64210).
- Legal form
- Société en commandite
- Legal situation
- Situation normale
- Date of incorporation
- 3 August 2012
- Main activity (NACE)
- 64210Activités de société holding
Secondary activities
13 additional NACE codes declared.
- 47730Commerce de détail de produits pharmaceutiques
- 70200Activités de conseil pour les affaires et autre conseil de gestion
- 47750Commerce de détail de produits cosmétiques et d'articles de toilette
- 47730Commerce de détail de produits pharmaceutiques
- 47741Commerce de détail d'articles médicaux et orthopédiques, à l'exception de lunettes de correction, de lentilles et de lunettes de soleil
- 73300Activités de conseil en relations publiques et communication
- 47730Commerce de détail de produits pharmaceutiques en magasin spécialisé
- 64200Activités des sociétés holding
Anti-money-laundering (AML) compliance
Is this activity subject to the Belgian anti-money-laundering obligations? An indicative assessment based on the declared NACE code.
Given its declared activity (“Activités de société holding”), Dfarma may be subject to anti-money-laundering obligations, under the conditions below.
Some business services fall under company service providers, which are obliged entities.
Conditions: Covered if the company professionally provides third parties with one of these services: taking part in the purchase or sale of shares in a company (other than a listed one), providing a statutory seat, or providing a commercial, postal or administrative address and related services (registered office). The AMLR (EU) 2024/1624 will widen this perimeter on 10 July 2027 (company formation, director mandates, nominee arrangements).
- Identification and verification of the client's identity (KYC)
- Identification of the ultimate beneficial owners (UBO register)
- Assessment of money-laundering and terrorist-financing risks
- Ongoing diligence and monitoring of transactions
- Reporting suspicions to the CTIF
- Retention of the documents and appointment of an AMLCO
Legal basis: art. 5, §1, 29° of the Act of 18 September 2017, referring to art. 3, 1° of the Act of 29 March 2018.
General information based on the declared NACE activity code; it is not legal advice. Whether the obligations actually apply depends on the activity effectively carried out.
Your risk analysis on this company
AML Company ran Dfarma through your due diligence questionnaire. Here are the first findings.
What is the geographic exposure of the client and of its transactions?
Belgium only· Registered office published in the register
What is the company's solvency and lifecycle status?
Trading, no proceedings· Legal situation published in the register
Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.
Run the full analysisThis preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.
Establishments
1 active establishment unit declared with the CBE.
Finances & financial health
Aggregate health score computed from the Altman Z″ model, completed with qualitative factors (age, regularity of filings, public alerts).
Financial data unavailable
This company's annual accounts carry no structured JSON (filings before 2022) or have not been published yet.
The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.
Notices in the Belgian Official Gazette
Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.
- MAATSCHAPPELIJKE ZETEL7 October 2015
Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.
What the Dfarma record does not say
Two readings of the register the raw data does not give: anti-money-laundering scope, and whether the filing deadline was met.
Is Dfarma subject to anti-money-laundering obligations in Belgium?
Did Dfarma file its annual accounts on time?
Company timeline
Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.
10 AI-analysed dimensions are not shown.
- 2024
- 2015
- 2012
Registry record since 7 September 2026
The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.
AI extraction of strategic AML data
The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.
- Legal life
- Restructuring
- Capital
- Legal form
- Incorporation
- Directors
- Beneficial owners
- Registered office
- Company name
- Notarial deeds
Similar companies
Same business sector and geographic area.
APOTHEEK ULRICKE CUYLEN
BIOCLIN
Apotheek Sielke Puype
APOTHEEK GODELAINE
APOTHEEK BULTYNCK
APOTHEEK VAN DENDER
APOTHEEK DENECKERE-DEMARE
STEDIPHAR
APOTHEEK DEHOUCK
Step it up
Full analysis unlocked.
Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.